Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging

Li-Chun Hsieh, John W Chen, Li-Ying Wang, Yuk-Ming Tsang, Pei-Wei Shueng, Li-Jen Liao, Wu-Chia Lo, Yu-Chin Lin, Chien-Fu Tseng, Ying-Shiung Kuo, Jie-Yang Jhuang, Hui-Ju Tien, Hsueh-Fen Juan, Chen-Hsi Hsieh, Li-Chun Hsieh, John W Chen, Li-Ying Wang, Yuk-Ming Tsang, Pei-Wei Shueng, Li-Jen Liao, Wu-Chia Lo, Yu-Chin Lin, Chien-Fu Tseng, Ying-Shiung Kuo, Jie-Yang Jhuang, Hui-Ju Tien, Hsueh-Fen Juan, Chen-Hsi Hsieh

Abstract

To develop magnetic resonance imaging (MRI) indicators to predict trismus outcome for post-operative oral cavity cancer patients who received adjuvant intensity-modulated radiation therapy (IMRT), 22 patients with oral cancer treated with IMRT were studied over a two-year period. Signal abnormality scores (SA scores) were computed from Likert-type ratings of the abnormalities of nine masticator structures and compared with the Mann-Whitney U-test and Kruskal-Wallis one-way ANOVA test between groups. Seventeen patients (77.3%) experienced different degrees of trismus during the two-year follow-up period. The SA score correlated with the trismus grade (r = 0.52, p<0.005). Patients having progressive trismus had higher mean doses of radiation to multiple structures, including the masticator and lateral pterygoid muscles, and the parotid gland (p<0.05). In addition, this group also had higher SA-masticator muscle dose product at 6 months and SA scores at 12 months (p<0.05). At the optimum cut-off points of 0.38 for the propensity score, the sensitivity was 100% and the specificity was 93% for predicting the prognosis of the trismus patients. The SA score, as determined using MRI, can reflect the radiation injury and correlate to trismus severity. Together with the radiation dose, it could serve as a useful biomarker to predict the outcome and guide the management of trismus following radiation therapy.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Describe the trismus related muscles…
Figure 1. Describe the trismus related muscles and structures that were targeted by colors in one of enrolled patients.
Light blue: left side medial pterygoid muscle; Pink: left side lateral pterygoid muscle; Light orange: left side temporalis; Forest green: left side masseter; Steel blue: left side temporomandibular joints. Sky blue: right side medial pterygoid muscle; Yellow: right side lateral pterygoid muscle; Yellow green: right side temporalis; Orange: right side masseter; Purple: right side temporomandibular joints.
Figure 2. Illustrated T1W MRI post-contrast enhancement…
Figure 2. Illustrated T1W MRI post-contrast enhancement of trismus patient after RT.
(a) Coronal view with fat saturation showed radiation effects in right lateral (white arrows), medial (black arrows) pterygoid muscles and masseter muscle (white arrowhead) with increased enhancement. (b) Coronal view showed atrophic change of the right lateral (white arrows), medial (black arrows) pterygoid muscles and masseter muscle (white arrowhead). (c) Axial view with fat saturation showed remarkable fibrotic tissue (white arrow) occupying right maxillary sinus and pterygoid space. (d) Axial view with fat saturation showed increased enhancement with atrophic change of the right parotid gland. All these findings were rated as point 2 according to our Likert scoring system of signal abnormality (SA score).
Figure 3. Comparison of signal abnormality scores…
Figure 3. Comparison of signal abnormality scores between different groups of trismus severity.
Significant difference in the SA scores between groups is noted (p = .03). The grade 3 group (most severe one) has the highest score and the grade 1 (least severe one) group has the lowest score.
Figure 4. Correlation of SA score with…
Figure 4. Correlation of SA score with radiation dose and the time trend of trismus development.
(a) Correlation of the received radiation dose of individual masticator structures with their two year SA scores summation (r = 0.48, p

Figure 5. Comparison of radiation doses and…

Figure 5. Comparison of radiation doses and SA scores between good prognosis and poor prognosis…

Figure 5. Comparison of radiation doses and SA scores between good prognosis and poor prognosis trismus groups.
A significant difference is noted in the mean dose of masticator structures (p = .04; Fig. 5a), mean dose of masticator muscles (p = .05; Fig. 5b), mean dose of lateral pterygoid muscles (p = .04; Fig. 5c), mean dose of parotid glands (p = .01; Fig. 5c), the product of the six month SA score with mean masticator muscles dose (p = .04; Fig. 5d) and the twelve month SA score (p = .01; Fig. 5e). (MP: medial pterygoid muscle; LP: lateral pterygoid muscle; Temp: temporalis muscle; TMJ: temporomandibular joint; PG: parotid gland; SA score: signal abnormality score; GP: good prognosis; PP: poor prognosis).
Figure 5. Comparison of radiation doses and…
Figure 5. Comparison of radiation doses and SA scores between good prognosis and poor prognosis trismus groups.
A significant difference is noted in the mean dose of masticator structures (p = .04; Fig. 5a), mean dose of masticator muscles (p = .05; Fig. 5b), mean dose of lateral pterygoid muscles (p = .04; Fig. 5c), mean dose of parotid glands (p = .01; Fig. 5c), the product of the six month SA score with mean masticator muscles dose (p = .04; Fig. 5d) and the twelve month SA score (p = .01; Fig. 5e). (MP: medial pterygoid muscle; LP: lateral pterygoid muscle; Temp: temporalis muscle; TMJ: temporomandibular joint; PG: parotid gland; SA score: signal abnormality score; GP: good prognosis; PP: poor prognosis).

References

    1. Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, et al. (2005) The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115: 1458–1460.
    1. Johnson J, van As-Brooks CJ, Fagerberg-Mohlin B, Finizia C (2010) Trismus in head and neck cancer patients in Sweden: incidence and risk factors. Med Sci Monit 16: CR278–282.
    1. Chua DT, Lo C, Yuen J, Foo YC (2001) A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol 24: 366–369.
    1. Qin DX, Hu YH, Yan JH, Xu GZ, Cai WM, et al. (1988) Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer 61: 1117–1124.
    1. Dijkstra PU, Kalk WW, Roodenburg JL (2004) Trismus in head and neck oncology: a systematic review. Oral Oncol 40: 879–889.
    1. Bhatia KS, King AD, Paunipagar BK, Abrigo J, Vlantis AC, et al. (2009) MRI findings in patients with severe trismus following radiotherapy for nasopharyngeal carcinoma. Eur Radiol 19: 2586–2593.
    1. Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, et al. (2010) A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 18: 1033–1038.
    1. Teguh DN, Levendag PC, Voet P, van der Est H, Noever I, et al. (2008) Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck 30: 622–630.
    1. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP (2003) Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14: 199–212.
    1. Chen WC, Hwang TZ, Wang WH, Lu CH, Chen CC, et al. (2009) Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncol 45: 505–510.
    1. Gomez DR, Zhung JE, Gomez J, Chan K, Wu AJ, et al. (2009) Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 73: 1096–1103.
    1. Yao M, Chang K, Funk GF, Lu H, Tan H, et al. (2007) The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the university of iowa experience. Int J Radiat Oncol Biol Phys 67: 1332–1341.
    1. Hsiung CY, Huang EY, Ting HM, Huang HY (2008) Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol 81: 809–814.
    1. Chen YY, Zhao C, Wang J, Ma HL, Lai SZ, et al. (2011) Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up. Cancer 117: 2910–2916.
    1. Louise Kent M, Brennan MT, Noll JL, Fox PC, Burri SH, et al. (2008) Radiation-induced trismus in head and neck cancer patients. Support Care Cancer 16: 305–309.
    1. Hsieh CH, Kuo YS, Liao LJ, Hu KY, Lin SC, et al. (2011) Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer. BMC Cancer 11: 37.
    1. Axel L (1987) Revised glossary of MR terms. Radiology 162: 874.
    1. Council on Scientific Affairs (1989) Musculoskeletal applications of magnetic resonance imaging. JAMA: the journal of the American Medical Association 262: 2420–2427.
    1. Keeling AN, Flaherty JD, Davarpanah AH, Ambrosy A, Farrelly CT, et al. (2011) Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. Journal of cardiovascular medicine 12: 460–468.
    1. Jansma J, Vissink A, Bouma J, Vermey A, Panders AK, et al. (1992) A survey of prevention and treatment regimens for oral sequelae resulting from head and neck radiotherapy used in Dutch radiotherapy institutes. Int J Radiat Oncol Biol Phys 24: 359–367.
    1. Liu Y, Chen M, Zhao C, Lu LX, Han F, et al. (2007) [Radiation-induced temporomandibular joint damage in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy]. Ai zheng = Aizheng = Chinese journal of cancer 26: 64–67.
    1. Steelman R, Sokol J (1986) Quantification of trismus following irradiation of the temporomandibular joint. Missouri dental journal 66: 21–23.
    1. Goldstein M, Maxymiw WG, Cummings BJ, Wood RE (1999) The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 88: 365–373.
    1. van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Rasch CR, et al. (2011) A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects. Dysphagia 26: 155–170.
    1. Israel HA, Ward JD, Horrell B, Scrivani SJ (2003) Oral and maxillofacial surgery in patients with chronic orofacial pain. J Oral Maxillofac Surg 61: 662–667.

Source: PubMed

3
Suscribir